Wysiwyg

Support from Alzheimer’s Impact Movement (AIM) corporate champions enables AIM to undertake important additional work to end Alzheimer’s and all other dementia.

No contribution from any entity impacts AIM decision-making, nor our positions on issues related to people living with Alzheimer’s, other dementia and their families. Total contributions from the pharmaceutical industry makes 3.55% of AIM’s total contributed revenue.

Platinum ($100,000)

Gold ($50,000)

Silver ($25,000)